EXOSC3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.034200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.283800E-01
Normal-vs-Stage2
2.769200E-01
Normal-vs-Stage3
2.835800E-01
Normal-vs-Stage4
5.224400E-01
Stage1-vs-Stage2
3.749000E-01
Stage1-vs-Stage3
2.198200E-01
Stage1-vs-Stage4
7.728600E-01
Stage2-vs-Stage3
4.114800E-01
Stage2-vs-Stage4
6.134000E-01
Stage3-vs-Stage4
3.529600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.017600E-01
Normal-vs-AfricanAmerican
2.141600E-01
Normal-vs-Asian
7.131200E-01
Caucasian-vs-AfricanAmerican
5.882800E-01
Caucasian-vs-Asian
2.844600E-01
AfricanAmerican-vs-Asian
2.919400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.516600E-01
Normal-vs-Female
3.776200E-01
Male-vs-Female
4.796200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.233400E-01
Normal-vs-Age(41-60Yrs)
3.188600E-01
Normal-vs-Age(61-80Yrs)
3.223800E-01
Normal-vs-Age(81-100Yrs)
2.822200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.885400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.018800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.650000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.088000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.591400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.728200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.568200E-01
Normal-vs-Daily Drinker
1.386840E-01
Normal-vs-Weekly Drinker
8.908800E-01
Normal-vs-Occasional Drinker
2.908000E-01
Normal-vs-Social Drinker
6.442600E-01
Non Drinker-vs-Daily Drinker
6.578400E-01
Non Drinker-vs-Weekly Drinker
1.312150E-01
Non Drinker-vs-Occasional Drinker
8.444600E-01
Non Drinker-vs-Social Drinker
1.791040E-01
Daily Drinker-vs-Weekly Drinker
1.156230E-01
Daily Drinker-vs-Occasional Drinker
5.398000E-01
Daily Drinker-vs-Social Drinker
7.555700E-02
Weekly Drinker-vs-Occasional Drinker
2.254000E-01
Weekly Drinker-vs-Social Drinker
7.313000E-01
Occasional Drinker-vs-Social Drinker
2.720800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.574200E-01
Normal-vs-Grade 2
8.765800E-01
Normal-vs-Grade 3
8.728800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.068200E-01
Grade 1-vs-Grade 3
7.199000E-01
Grade 1-vs-Grade 4
8.574200E-01
Grade 2-vs-Grade 3
9.025000E-01
Grade 2-vs-Grade 4
8.765800E-01
Grade 3-vs-Grade 4
8.728800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.145400E-01
Normal-vs-NonDiabetic
2.863400E-01
Diabetic-vs-NonDiabetic
6.117000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.017600E-02
Normal-vs-NoPancreatitis
3.402200E-01
Pancreatitis-vs-NoPancreatitis
8.324000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.567800E-01
Normal-vs-N1
2.734400E-01
N0-vs-N1
1.526020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.036200E-01
Normal-vs-TP53-NonMutant
3.250400E-01
TP53-Mutant-vs-TP53-NonMutant
8.209200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
